ZimVie Inc (ZIMV) AI Stock Analysis

• Market Cap: $244.31M
• Dividend Yield: N/A
• Average Volume (3M): 147.55K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.28
• Revenue Growth: -32.70%
• EPS Growth: 94.89%
• Country: US
• Employees: 1,770
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Devices
• EPS (TTM): 0.27
• Shares Outstanding: 27,921,549
• 10 Day Avg. Volume: 189,780
• 30 Day Avg. Volume: 147,554
• PEG Ratio: -0.10
• Price to Book (P/B): 0.63
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 32.56
• Enterprise Value/Market Cap: 1.64
• Enterprise Value/Revenue: 0.19
• Enterprise Value/Gross Profit: 1.49
• Enterprise Value/Ebitda: 2.19
• 1Y Price Target: $11.67
• Price Target Upside: 31.42% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 4

• Rating: 46 Neutral
• Price Target: $8.50 ▼( -4.28% Downside)

ZimVie Inc faces significant challenges, with declining revenues and persistent net losses impacting financial performance. Despite improvements in debt reduction and cash flow management, technical analysis indicates negative momentum. Valuation issues, highlighted by a negative P/E ratio, further contribute to a low overall score.

Positive Factors

Market Stability

The overall health of the dental market was discussed, indicating stability and potential growth opportunities for Zimvie Inc.

Profitability

Profitability was strong and ZIMV is able to absorb a modest impact from tariffs.

Revenue Growth

In early April, ZIMV acquired a distributor in Costa Rica for $3.3M which should be accretive to revenue and margins.

Negative Factors

Cost Structure

Tariffs were mentioned as a factor that could impact the company's cost structure.

Product Performance

Implants and scanners were the two weakest product groups in the quarter.

Revenue Performance

ZIMV missed consensus revenue while adjusted EBITDA beat expectations in 1Q25.

ZimVie Inc Business Overview & Revenue Model

Company Description

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

How the Company Makes Money

ZimVie Inc generates revenue through the sale of its medical devices and solutions, primarily in the dental and spine health sectors. The company's key revenue streams include the sale of dental implants and related surgical instruments, as well as spinal solutions designed to address a variety of spine-related health issues. Additionally, ZimVie may establish partnerships with healthcare providers, distributors, and other stakeholders to expand its market reach and increase sales. The company focuses on innovation and the development of new products to meet the evolving needs of healthcare professionals and patients, contributing to its revenue growth.

ZimVie Inc Financial Statement Overview

Summary

ZimVie Inc faces challenges with declining revenues and consistent net losses affecting profitability. However, the company has improved its balance sheet by reducing debt to zero and maintaining positive cash flow management. Overall, significant operational improvements are needed to achieve profitability.

Income Statement

ZimVie Inc has been experiencing a consistent decline in revenue over the past years, with a significant revenue decrease of 50.76% from 2019 to 2024. The gross profit margin has remained strong at 100% in 2024, but this is due to significant cost reductions rather than revenue growth. The company consistently reports negative net income, resulting in negative net profit margins, indicating ongoing profitability challenges. Both EBIT and EBITDA margins have been negative, reflecting non-operational inefficiencies.

Balance Sheet

The balance sheet reflects a relatively stable equity ratio of about 50.6% in 2024, indicating moderate financial leverage. The company has managed to reduce its total debt to zero by 2024, significantly improving its debt-to-equity ratio from 1.27 in 2020 to 0 in 2024. However, the return on equity remains negative due to consistent net losses, indicating inefficient use of equity capital.

Cash Flow

ZimVie Inc has shown some positive trends in cash flow management. Despite operating challenges, the company has managed to maintain positive operating cash flow and free cash flow in recent years. The free cash flow declined significantly in 2024, but the company has a strong operating cash flow to net income ratio, indicating good cash generation relative to net earnings, albeit the latter being negative.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
449.75M	457.43M	913.86M	1.01B	912.40M
	Gross Profit
287.45M	290.38M	613.08M	628.80M	599.50M
	EBIT
-20.66M	-30.94M	-50.85M	-73.60M	-67.10M
	EBITDA
29.61M	91.07M	79.16M	28.70M	-86.70M
	Net Income Common Stockholders
-25.82M	-393.28M	-63.88M	-95.30M	-179.00M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
74.97M	71.51M	89.60M	100.40M	27.40M
	Total Assets
753.67M	1.21B	1.64B	1.83B	1.95B
	Total Debt
232.57M	521.93M	564.14M	57.90M	89.20M
	Net Debt
157.60M	450.42M	474.54M	-42.50M	61.80M
	Total Liabilities
371.97M	795.85M	883.45M	375.30M	458.70M
	Stockholders Equity
381.71M	409.49M	758.60M	1.45B	1.49B
Cash Flow		Free Cash Flow
7.49M	24.66M	-1.92M	7.70M	47.70M
	Operating Cash Flow
14.17M	37.15M	24.63M	64.30M	86.00M
	Investing Cash Flow
282.30M	-15.17M	-28.66M	-60.30M	-49.50M
	Financing Cash Flow
-294.67M	-25.67M	-1.31M	72.30M	-46.50M

ZimVie Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 8.88
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ZIMV, the sentiment is Negative. The current price of 8.88 is below the 20-day moving average (MA) of 9.00, below the 50-day MA of 9.91, and below the 200-day MA of 13.56, indicating a bearish trend. The MACD of -0.33 indicates Negative momentum. The RSI at 37.87 is Neutral, neither overbought nor oversold. The STOCH value of 22.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ZIMV.

ZimVie Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PODD	76 Outperform	$22.93B	58.93	37.92%	―	23.49%	71.25%
STE	76 Outperform	$24.81B	40.73	9.45%	0.89%	-0.17%	-17.34%
ZBH	70 Outperform	$18.95B	21.22	7.31%	1.01%	3.30%	-2.39%
LIVN	63 Neutral	$2.45B	30.62	-19.69%	―	7.97%	-592.40%
Sector *	53 Neutral	$5.24B	3.07	-43.58%	2.80%	16.87%	-0.11%
OFIX	47 Neutral	$472.52M	―	-27.82%	―	5.85%	-8.92%
ZIMV	46 Neutral	$244.31M	―	-6.35%	―	-32.70%	94.89%

ZimVie Inc Corporate Events

ZimVie Inc Holds Annual Shareholders Meeting

ZimVie Inc. held its annual shareholders meeting on May 7, 2025, where key decisions were made regarding company governance and executive compensation. Shareholders elected a Class III director, ratified PricewaterhouseCoopers LLP as the independent auditor for 2025, and approved the executive compensation plan on a non-binding advisory basis.

The most recent analyst rating on (ZIMV) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on ZimVie Inc stock, see the ZIMV Stock Forecast page.

Spark’s Take on ZIMV Stock

According to Spark, TipRanks’ AI Analyst, ZIMV is a Neutral.

ZimVie’s overall stock score reflects significant financial challenges, including declining revenues and negative profitability, countered by positive cash flow management and debt reduction. Technical indicators suggest bearish momentum, while valuation remains unattractive due to a negative P/E ratio. Strategic shifts highlighted in earnings calls and corporate events show potential for long-term improvement, but current operational inefficiencies remain a concern.

To see Spark’s full report on ZIMV stock, click here.

ZimVie Inc Reports Q1 2025 Financial Results

On May 8, 2025, ZimVie Inc. reported its financial results for the first quarter of 2025, showing net sales of $112.0 million, which marked a 5.2% decrease compared to the same period in 2024. Despite a net loss of $2.6 million, the company improved its net loss margin significantly from the previous year. Adjusted EBITDA increased to $17.6 million, reflecting a 15.7% margin. The company remains focused on operational efficiency and profitability improvements, aiming for a return to top-line growth.

Spark’s Take on ZIMV Stock

According to Spark, TipRanks’ AI Analyst, ZIMV is a Neutral.

ZimVie Inc faces ongoing challenges with declining revenue and negative net income, impacting its financial performance. The stock is under negative technical momentum, and its valuation is hindered by a negative P/E ratio. While the company has improved its balance sheet by eliminating debt, significant operational improvements are needed to achieve profitability.

To see Spark’s full report on ZIMV stock, click here.

ZimVie Inc Announces Board Leadership Changes

On March 7, 2025, David King, the Non-Executive Chair of ZimVie Inc.’s Board of Directors, announced he will not seek reelection at the company’s annual meeting on May 7, 2025. His decision is not due to any disagreement with the company. The Board will reduce its size to five members following his departure and has appointed Vafa Jamali as the new Chairman and Vinit Asar as the Lead Independent Director, effective May 7, 2025.

ZimVie Inc Reports 2024 Financial Results and Transformation

On February 26, 2025, ZimVie Inc. reported its financial results for the fourth quarter and full year of 2024, highlighting a transformational year where the company became a pure play dental company. Despite a slight decrease in net sales, the company improved its financial profile by reducing net debt by over $290 million and increasing adjusted EBITDA margins. The net loss for the year improved significantly compared to 2023, and the company expressed optimism about the growth potential in the dental implant market for 2025 and beyond.